This document provides an overview of VICH guidelines related to stability testing. It lists several VICH guidelines including GL3, GL4, GL5, GL8, GL45, GL51, and GL17. GL3 is identified as the parent guideline for stability testing of new drug substances and products. The document also defines key terms including new dosage form, medicated premix, and biotechnological/biological product as they relate to the scope and application of the VICH stability guidelines. It provides a high-level description of the structure and objectives of the VICH stability guidance documents.